CD8+ T cells are the most prevailing lymphocyte population in early MS lesions but they may remain in the brain and spinal cord as tissue‐resident cells propagating focal neuroinflammation associated with aging (Lassmann, 2019). The gene discussed is CD8A; the disease is myeloid sarcoma.